97 related articles for article (PubMed ID: 22198116)
1. Anthraquinone antitumour agents, doxorubicin, pirarubicin and benzoperimidine BP1, trigger caspase-3/caspase-8-dependent apoptosis of leukaemia sensitive HL60 and resistant HL60/VINC and HL60/DOX cells.
Nowak R; Tarasiuk J
Anticancer Drugs; 2012 Apr; 23(4):380-92. PubMed ID: 22198116
[TBL] [Abstract][Full Text] [Related]
2. Retaining cytotoxic activity of anthrapyridone CO1 against multidrug resistant cells is related to the ability to induce concomitantly apoptosis and lysosomal death of leukaemia HL60/VINC and HL60/DOX cells.
Nowak R; Tarasiuk J
J Pharm Pharmacol; 2013 Jun; 65(6):855-67. PubMed ID: 23647679
[TBL] [Abstract][Full Text] [Related]
3. Bioreductive Activation of Antitumour Drugs, Doxorubicin and Pirarubicin, Does Not Affect Their Ability to Induce Apoptosis of Sensitive and Multidrug Resistant Leukaemia HL60 Cells.
Kostrzewa-Nowak D; Tarasiuk J
Anticancer Res; 2021 Mar; 41(3):1429-1438. PubMed ID: 33788734
[TBL] [Abstract][Full Text] [Related]
4. Bioreductive activation of mitoxantrone by NADPH cytochrome P450 reductase does not change its apoptotic stimuli properties in regard to sensitive and multidrug resistant leukaemia HL60 cells.
Kostrzewa-Nowak D; Tarasiuk J
Eur J Pharmacol; 2013 Dec; 721(1-3):141-50. PubMed ID: 24076328
[TBL] [Abstract][Full Text] [Related]
5. Role of structural factors of antitumour anthraquinone derivatives and analogues in the ability to undergo bioreductive activation by NADPH cytochrome P450 reductase: implications for increasing the activity against sensitive and multidrug-resistant leukaemia HL60 cells.
Kostrzewa-Nowak D; Bieg B; Paine MJ; Wolf CR; Tarasiuk J
Anticancer Drugs; 2012 Apr; 23(4):393-405. PubMed ID: 22205152
[TBL] [Abstract][Full Text] [Related]
6. The ability of selected pyridinium salts to increase the cytotoxic activity of vincristine but not doxorubicin towards sensitive and multidrug resistant promyelocytic leukaemia HL60 cells.
Maruszewska A; Kostrzewa-Nowak D; Adamus J; Czupryńska K; Maryniak D; Gebicki J; Tarasiuk J
J Pharm Pharmacol; 2008 May; 60(5):647-53. PubMed ID: 18416942
[TBL] [Abstract][Full Text] [Related]
7. The role of bioreductive activation of antitumour anthracycline drugs in cytotoxic activity against sensitive and multidrug resistant leukaemia HL60 cells.
Kostrzewa-Nowak D; Bieg B; Paine MJ; Wolf CR; Tarasiuk J
Eur J Pharmacol; 2012 Jan; 674(2-3):112-25. PubMed ID: 22115891
[TBL] [Abstract][Full Text] [Related]
8. The role of bioreductive activation of doxorubicin in cytotoxic activity against leukaemia HL60-sensitive cell line and its multidrug-resistant sublines.
Kostrzewa-Nowak D; Paine MJ; Wolf CR; Tarasiuk J
Br J Cancer; 2005 Jul; 93(1):89-97. PubMed ID: 15942634
[TBL] [Abstract][Full Text] [Related]
9. Antitumour Effects of Selected Pyridinium Salts on Sensitive Leukaemia HL60 Cells and Their Multidrug Resistant Topoisomerase II-Defective HL60/MX2 Counterparts.
Tarasiuk J; Kostrzewa-Nowak D; Żwierełło W
Molecules; 2022 Aug; 27(16):. PubMed ID: 36014378
[TBL] [Abstract][Full Text] [Related]
10. Antitumour effects of selected plant polyphenols, gallic acid and ellagic acid, on sensitive and multidrug-resistant leukaemia HL60 cells.
Maruszewska A; Tarasiuk J
Phytother Res; 2019 Apr; 33(4):1208-1221. PubMed ID: 30838722
[TBL] [Abstract][Full Text] [Related]
11. Resistance to diverse apoptotic triggers in multidrug resistant HL60 cells and its possible relationship to the expression of P-glycoprotein, Fas and of the novel anti-apoptosis factors IAP (inhibitory of apoptosis proteins).
Notarbartolo M; Cervello M; Dusonchet L; Cusimano A; D'Alessandro N
Cancer Lett; 2002 Jun; 180(1):91-101. PubMed ID: 11911975
[TBL] [Abstract][Full Text] [Related]
12. Transport mechanism of anthracycline derivatives in human leukemia cell lines: uptake and efflux of pirarubicin in HL60 and pirarubicin-resistant HL60 cells.
Nagasawa K; Natazuka T; Chihara K; Kitazawa F; Tsumura A; Takara K; Nomiyama M; Ohnishi N; Yokoyama T
Cancer Chemother Pharmacol; 1996; 37(4):297-304. PubMed ID: 8548874
[TBL] [Abstract][Full Text] [Related]
13. Bioreductive activation of mitoxantrone by NADPH cytochrome P450 reductase. Implications for increasing its ability to inhibit the growth of sensitive and multidrug resistant leukaemia HL60 cells.
Kostrzewa-Nowak D; Paine MJ; Korytowska A; Serwatka K; Piotrowska S; Wolf CR; Tarasiuk J
Cancer Lett; 2007 Jan; 245(1-2):252-62. PubMed ID: 16574318
[TBL] [Abstract][Full Text] [Related]
14. The activity of latent benzoperimidine esters to inhibit P-glycoprotein and multidrug resistance-associated protein 1 dependent efflux of pirarubicin from several lines of multidrug resistant tumor cells.
Głowacka-Rogacka D; Arciemiuk M; Kupiec A; Bontemps-Gracz MM; Borowski E; Tarasiuk J
Cancer Detect Prev; 2004; 28(4):283-93. PubMed ID: 15350632
[TBL] [Abstract][Full Text] [Related]
15. Proteinase-3, a serine protease which mediates doxorubicin-induced apoptosis in the HL-60 leukemia cell line, is downregulated in its doxorubicin-resistant variant.
Wu CH; Gordon J; Rastegar M; Ogretmen B; Safa AR
Oncogene; 2002 Aug; 21(33):5160-74. PubMed ID: 12140766
[TBL] [Abstract][Full Text] [Related]
16. Reversal of P-glycoprotein-mediated multidrug resistance by guggulsterone in doxorubicin-resistant human myelogenous leukemia (K562/DOX) cells.
Xu HB; Li L; Liu GQ
Pharmazie; 2009 Oct; 64(10):660-5. PubMed ID: 19947169
[TBL] [Abstract][Full Text] [Related]
17. The activity of Selol in multidrug-resistant and sensitive human leukemia cells.
Suchocki P; Misiewicz I; Skupinska K; Waclawek K; Fijalek Z; Kasprzycka-Guttman T
Oncol Rep; 2007 Oct; 18(4):893-9. PubMed ID: 17786352
[TBL] [Abstract][Full Text] [Related]
18. beta(2)-microglobulin induces apoptosis in HL-60 human leukemia cell line and its multidrug resistant variants overexpressing MRP1 but lacking Bax or overexpressing P-glycoprotein.
Wu CH; Rastegar M; Gordon J; Safa AR
Oncogene; 2001 Oct; 20(48):7006-20. PubMed ID: 11704825
[TBL] [Abstract][Full Text] [Related]
19. Reduction of doxorubicin resistance by tetrandrine and dauricine in harringtonine-resistant human leukemia (HL60) cells.
He QY; Meng FH; Zhang HQ
Zhongguo Yao Li Xue Bao; 1996 Mar; 17(2):179-81. PubMed ID: 9772674
[TBL] [Abstract][Full Text] [Related]
20. Effects of monensin liposomes on the cytotoxicity, apoptosis and expression of multidrug resistance genes in doxorubicin-resistant human breast tumour (MCF-7/dox) cell-line.
Shaik MS; Chatterjee A; Singh M
J Pharm Pharmacol; 2004 Jul; 56(7):899-907. PubMed ID: 15233869
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
